Disease, Wellness and Longevity Claims: The US Evidence and Scope Boundary
US labeling and advertising frameworks address different questions. Product category, implied meaning and evidence must be assessed together.
LongevityNext
Research Notes and Articles
What an Aging-Drug Claim Must Define: A US Regulatory Evidence Framework
The practical issue is a defined product, population, intended use and benefit-risk case—not whether “aging” is an appealing category label.